Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001964306-23-000147
Filing Date
2023-08-07
Accepted
2023-08-07 17:15:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2848
  Complete submission text file 0001964306-23-000147.txt   4161
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Subject) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38693 | Film No.: 231148510
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2000 GALLOPING HILL RD KENILWORTH NJ 07033
Business Address
Mayo Stephen (Reporting) CIK: 0001849061 (see all company filings)

Type: 144